Cargando…

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance

We analyzed MYD88 and CXCR4 mutation status of 260 patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance using allele-specific real time quantitative polymerase chain reaction and Sanger sequencing, respectively. A subgroup of 119 patients was further...

Descripción completa

Detalles Bibliográficos
Autores principales: Varettoni, Marzia, Zibellini, Silvia, Defrancesco, Irene, Ferretti, Virginia Valeria, Rizzo, Ettore, Malcovati, Luca, Gallì, Anna, Porta, Matteo Giovanni Della, Boveri, Emanuela, Arcaini, Luca, Candido, Chiara, Paulli, Marco, Cazzola, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709107/
https://www.ncbi.nlm.nih.gov/pubmed/28983055
http://dx.doi.org/10.3324/haematol.2017.172718
_version_ 1783282734794276864
author Varettoni, Marzia
Zibellini, Silvia
Defrancesco, Irene
Ferretti, Virginia Valeria
Rizzo, Ettore
Malcovati, Luca
Gallì, Anna
Porta, Matteo Giovanni Della
Boveri, Emanuela
Arcaini, Luca
Candido, Chiara
Paulli, Marco
Cazzola, Mario
author_facet Varettoni, Marzia
Zibellini, Silvia
Defrancesco, Irene
Ferretti, Virginia Valeria
Rizzo, Ettore
Malcovati, Luca
Gallì, Anna
Porta, Matteo Giovanni Della
Boveri, Emanuela
Arcaini, Luca
Candido, Chiara
Paulli, Marco
Cazzola, Mario
author_sort Varettoni, Marzia
collection PubMed
description We analyzed MYD88 and CXCR4 mutation status of 260 patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance using allele-specific real time quantitative polymerase chain reaction and Sanger sequencing, respectively. A subgroup of 119 patients was further studied with next-generation sequencing of 11 target genes (MYD88, CXCR4, ARID1A, KMT2D, NOTCH2, TP53, PRDM1, CD79B, TRAF3, MYBBP1A, and TNFAIP3). MYD88 (L265P) was found at diagnosis in 91% of patients with Waldenström macroglobulinemia and in 60% of patients with IgM monoclonal gammopathy of undetermined significance using allele-specific polymerase chain reaction analysis. MYD88 mutations other than the classical L265P (V217F, S219C and M232T) were found in four cases by next-generation sequencing. Waldenström macroglobulinemia patients with wild-type MYD88 had a distinct clinical phenotype characterized by less bone marrow infiltration (P=0.01) and more frequent extramedullary involvement (P=0.001) compared to patients with mutated MYD88. Patients with wild-type MYD88 did not show additional mutations in the other target genes. CXCR4 mutations were found by Sanger sequencing in 22% of patients with Waldenström macroglobulinemia. With next-generation sequencing, a CXCR4 mutation was detected in 23% of patients with Waldenström macroglobulinemia and 9% of those with IgM monoclonal gammopathy of undetermined significance. Asymptomatic Waldenström macroglobulinemia patients harboring a CXCR4 mutation had a shorter treatment-free survival (51 months) than that of patients with wild-type CXCR4 (median not reached) (P=0.007). Analysis of variant allele frequencies indicated that CXCR4 mutations were present in the dominant clone in the majority of cases. Recurrent somatic mutations of KMT2D were found in 24% of patients with Waldenström macroglobulinemia and 5% of patients with IgM monoclonal gammopathy of undetermined significance and were primarily subclonal.
format Online
Article
Text
id pubmed-5709107
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Ferrata Storti Foundation
record_format MEDLINE/PubMed
spelling pubmed-57091072017-12-12 Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance Varettoni, Marzia Zibellini, Silvia Defrancesco, Irene Ferretti, Virginia Valeria Rizzo, Ettore Malcovati, Luca Gallì, Anna Porta, Matteo Giovanni Della Boveri, Emanuela Arcaini, Luca Candido, Chiara Paulli, Marco Cazzola, Mario Haematologica Article We analyzed MYD88 and CXCR4 mutation status of 260 patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance using allele-specific real time quantitative polymerase chain reaction and Sanger sequencing, respectively. A subgroup of 119 patients was further studied with next-generation sequencing of 11 target genes (MYD88, CXCR4, ARID1A, KMT2D, NOTCH2, TP53, PRDM1, CD79B, TRAF3, MYBBP1A, and TNFAIP3). MYD88 (L265P) was found at diagnosis in 91% of patients with Waldenström macroglobulinemia and in 60% of patients with IgM monoclonal gammopathy of undetermined significance using allele-specific polymerase chain reaction analysis. MYD88 mutations other than the classical L265P (V217F, S219C and M232T) were found in four cases by next-generation sequencing. Waldenström macroglobulinemia patients with wild-type MYD88 had a distinct clinical phenotype characterized by less bone marrow infiltration (P=0.01) and more frequent extramedullary involvement (P=0.001) compared to patients with mutated MYD88. Patients with wild-type MYD88 did not show additional mutations in the other target genes. CXCR4 mutations were found by Sanger sequencing in 22% of patients with Waldenström macroglobulinemia. With next-generation sequencing, a CXCR4 mutation was detected in 23% of patients with Waldenström macroglobulinemia and 9% of those with IgM monoclonal gammopathy of undetermined significance. Asymptomatic Waldenström macroglobulinemia patients harboring a CXCR4 mutation had a shorter treatment-free survival (51 months) than that of patients with wild-type CXCR4 (median not reached) (P=0.007). Analysis of variant allele frequencies indicated that CXCR4 mutations were present in the dominant clone in the majority of cases. Recurrent somatic mutations of KMT2D were found in 24% of patients with Waldenström macroglobulinemia and 5% of patients with IgM monoclonal gammopathy of undetermined significance and were primarily subclonal. Ferrata Storti Foundation 2017-12 /pmc/articles/PMC5709107/ /pubmed/28983055 http://dx.doi.org/10.3324/haematol.2017.172718 Text en Copyright© 2017 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
spellingShingle Article
Varettoni, Marzia
Zibellini, Silvia
Defrancesco, Irene
Ferretti, Virginia Valeria
Rizzo, Ettore
Malcovati, Luca
Gallì, Anna
Porta, Matteo Giovanni Della
Boveri, Emanuela
Arcaini, Luca
Candido, Chiara
Paulli, Marco
Cazzola, Mario
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
title Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
title_full Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
title_fullStr Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
title_full_unstemmed Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
title_short Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
title_sort pattern of somatic mutations in patients with waldenström macroglobulinemia or igm monoclonal gammopathy of undetermined significance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709107/
https://www.ncbi.nlm.nih.gov/pubmed/28983055
http://dx.doi.org/10.3324/haematol.2017.172718
work_keys_str_mv AT varettonimarzia patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT zibellinisilvia patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT defrancescoirene patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT ferrettivirginiavaleria patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT rizzoettore patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT malcovatiluca patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT gallianna patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT portamatteogiovannidella patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT boveriemanuela patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT arcainiluca patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT candidochiara patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT paullimarco patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance
AT cazzolamario patternofsomaticmutationsinpatientswithwaldenstrommacroglobulinemiaorigmmonoclonalgammopathyofundeterminedsignificance